[go: up one dir, main page]

EP1006801A4 - Cellules de sertoli utilisees comme cellules induisant la recuperation neurologique en cas de troubles neurodegeneratifs - Google Patents

Cellules de sertoli utilisees comme cellules induisant la recuperation neurologique en cas de troubles neurodegeneratifs

Info

Publication number
EP1006801A4
EP1006801A4 EP96908758A EP96908758A EP1006801A4 EP 1006801 A4 EP1006801 A4 EP 1006801A4 EP 96908758 A EP96908758 A EP 96908758A EP 96908758 A EP96908758 A EP 96908758A EP 1006801 A4 EP1006801 A4 EP 1006801A4
Authority
EP
European Patent Office
Prior art keywords
event
cells
neurodegenerative disorders
neurological recovery
sertoli
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP96908758A
Other languages
German (de)
English (en)
Other versions
EP1006801A1 (fr
Inventor
Paul R Sanberg
Don F Cameron
Cesario V Borlongan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of South Florida
University of South Florida St Petersburg
Original Assignee
University of South Florida
University of South Florida St Petersburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/402,389 external-priority patent/US5702700A/en
Application filed by University of South Florida, University of South Florida St Petersburg filed Critical University of South Florida
Publication of EP1006801A1 publication Critical patent/EP1006801A1/fr
Publication of EP1006801A4 publication Critical patent/EP1006801A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Developmental Biology & Embryology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
EP96908758A 1995-03-13 1996-03-12 Cellules de sertoli utilisees comme cellules induisant la recuperation neurologique en cas de troubles neurodegeneratifs Withdrawn EP1006801A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US402389 1989-09-01
US08/402,389 US5702700A (en) 1995-03-13 1995-03-13 Sertoli cells as neurorecovery inducing cells for Parkinson's disease
PCT/US1996/003335 WO1996028030A1 (fr) 1995-03-13 1996-03-12 Cellules de sertoli utilisees comme cellules induisant la recuperation neurologique en cas de troubles neurodegeneratifs

Publications (2)

Publication Number Publication Date
EP1006801A1 EP1006801A1 (fr) 2000-06-14
EP1006801A4 true EP1006801A4 (fr) 2001-05-02

Family

ID=23591681

Family Applications (1)

Application Number Title Priority Date Filing Date
EP96908758A Withdrawn EP1006801A4 (fr) 1995-03-13 1996-03-12 Cellules de sertoli utilisees comme cellules induisant la recuperation neurologique en cas de troubles neurodegeneratifs

Country Status (7)

Country Link
EP (1) EP1006801A4 (fr)
JP (1) JP3699727B2 (fr)
KR (1) KR100297899B1 (fr)
AU (1) AU705932B2 (fr)
CA (1) CA2215343C (fr)
NZ (1) NZ304646A (fr)
TW (1) TW427907B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9401192L (sv) * 1994-04-11 1995-10-12 Jne Ab Symmetrimätanordning
SE524543C2 (sv) 2002-01-17 2004-08-24 Jne Ab Mätlinjal, avsedd för symmetrimätningar på fordon
ATE492636T1 (de) 2002-10-22 2011-01-15 Eisai R&D Man Co Ltd Spezifisch in postmitotischen dopamin- produzierenden neuronalen vorläuferzellen exprimiertes gen
CA2574177C (fr) 2004-07-22 2019-01-08 Eisai Co., Ltd. Lrp4/corine, marqueurs de cellules progeniteurs neuronaux dopaminergiques
EP2006382B1 (fr) 2006-04-11 2016-08-03 Eisai R&D Management Co., Ltd. Marqueur 187a5 d'une cellule progenitrice de neurones synthetisant de la dopamine

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992006702A1 (fr) * 1990-10-19 1992-04-30 New York University Procede de transplantation de cellules dans le cerveau et utilisations therapeutiques du procede

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5082670A (en) * 1988-12-15 1992-01-21 The Regents Of The University Of California Method of grafting genetically modified cells to treat defects, disease or damage or the central nervous system
US5702700A (en) * 1995-03-13 1997-12-30 University Of South Florida Sertoli cells as neurorecovery inducing cells for Parkinson's disease

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992006702A1 (fr) * 1990-10-19 1992-04-30 New York University Procede de transplantation de cellules dans le cerveau et utilisations therapeutiques du procede

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
BORLONGAN CV ET AL: "CNS immunological modulation of neural graft rejection and survival", NEUROLOGICAL RESEARCH, vol. 18, August 1996 (1996-08-01), pages 297 - 304, XP000983230 *
DE CESARIS P ET AL.: "Immunosuppressive molecules produced by Sertoli cells cultured in vitro: biological effects on lymphocytes", BIOCHEM BIOPHYS RES COMMUN, vol. 186, no. 3, 14 August 1992 (1992-08-14), pages 1639 - 1646, XP000942038 *
ROBERTS K P ET AL: "IMMORTALIZATION AND CHARACTERIZATION OF A SERTOLI CELL LINE FROM THE ADULT RAT", BIOLOGY OF REPRODUCTION,US,SOCIETY FOR THE STUDY OF REPRODUCTION, CHAMPAIGN, IL, vol. 53, no. 6, 1 December 1995 (1995-12-01), pages 1446 - 1453, XP000602206, ISSN: 0006-3363 *
SANBERG P R ET AL: "SERTOLI CELLS - AN ALTERNATIVE CELL SOURCE FOR NEURAL TRANSPLANTATION IN PARKINSONS-DISEASE", EXPERIMENTAL NEUROLOGY, ( OCT 1995 ) VOL. 135, NO. 2, PP. 169. ISSN: 0014-4886., XP000983205 *
SANBERG PAUL R ET AL: "Testis-derived Sertoli cells survive and provide localized immunoprotection for xenografts in rat brain.", NATURE BIOTECHNOLOGY, vol. 14, no. 13, 1996, pages 1692 - 1695, XP000942044, ISSN: 1087-0156 *
SANBERG, P. R. (1) ET AL: "Functional recovery in hemiparkinsonian rats following neural transplantation of testis-derived Sertoli cells.", SOCIETY FOR NEUROSCIENCE ABSTRACTS, (1995) VOL. 21, NO. 1-3, PP. 317. MEETING INFO.: 25TH ANNUAL MEETING OF THE SOCIETY FOR NEUROSCIENCE SAN DIEGO, CALIFORNIA, USA NOVEMBER 11-16, 1995, XP000983272 *
See also references of WO9628030A1 *
SELAWRY H P ET AL: "Production of a factor, or factors, suppressing IL-2 production and T cel proliferation by Sertoli cell-enriched preparations. A potentia role for islet transplantation in an immunologically privileged site.", TRANSPLANTATION, (1991 NOV) 52 (5) 846-50., XP000602288 *
WYATT CR ET AL: "Suppression of lymphocyte proliferation by proteins secreted by cultured Sertoli cells", J REPRODUC IMMUNOL, vol. 14, 1988, pages 27 - 40, XP000983203 *

Also Published As

Publication number Publication date
AU5189796A (en) 1996-10-02
JPH11501818A (ja) 1999-02-16
EP1006801A1 (fr) 2000-06-14
JP3699727B2 (ja) 2005-09-28
CA2215343A1 (fr) 1996-09-19
CA2215343C (fr) 2002-02-19
KR100297899B1 (ko) 2001-10-25
NZ304646A (en) 1998-01-26
AU705932B2 (en) 1999-06-03
KR19980703028A (ko) 1998-09-05
MX9707028A (es) 1998-06-28
TW427907B (en) 2001-04-01

Similar Documents

Publication Publication Date Title
GB2305605B (en) Pipecolic acid derivatives for the treatment of neurological disorders
AU2132497A (en) Auto refresh to specified bank
AUPM864894A0 (en) Treatment of bowel-dependent neurological disorders
FR2771950B1 (fr) Procede de regeneration de catalyseurs et d'adsorbants
GB9605306D0 (en) Sertoli cells as neurorecovery inducing cellsfor neurodegenerative disorders
ITMI950243A0 (it) Differenziale in particolare per veicoli
EP1006801A4 (fr) Cellules de sertoli utilisees comme cellules induisant la recuperation neurologique en cas de troubles neurodegeneratifs
FR2754816B1 (fr) Procede de purification d'hydrogenochlorofluoroethanes
DE69633147D1 (de) Herstellung von Kennzeichenschildern für Fahrzeuge
NO974569L (no) Benzamider for behandling av neurodegenerative forstyrrelser
EP0958390A4 (fr) Perfectionnement du procede de recuperation de metaux
AU4489397A (en) The use of calpain inhibitors to treat ocular neural pathology
KR970047091U (ko) 자동차의 밧데리 전극
KR960036838U (ko) 청각장애자용 차량의 대쉬보드
KR960027019U (ko) 자동차의 파워 스티어링장치
KR970007241U (ko) 차량용 베터리구조
KR970035344U (ko) 차량사고시 알람 발생장치
KR970030458U (ko) 차량의 버튼식 워터 세퍼레이터
KR970031350U (ko) 자동차 계기판 분리장치
HK1013254B (en) Pipecolic acid derivatives for the treatment of neurological disorders
KR970035368U (ko) 버스의 운전석 분리용 세퍼레이터
KR970011246U (ko) 전기자동차용 밧데리의 케이스
KR970040365U (ko) 자동차의 블로바이가스 여과구조
KR970005946U (ko) 도로의 중앙 분리대
GB9417350D0 (en) Inter-changeable traction battery for road vehicles

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19971007

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20010321

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61K 35/00 A, 7A 01N 63/00 B, 7C 12N 5/06 B

17Q First examination report despatched

Effective date: 20021021

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20030503